Detalhe da pesquisa
1.
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial.
Gastric Cancer;
27(3): 558-570, 2024 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38308771
2.
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study.
Lancet Oncol;
23(11): 1430-1440, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36244398
3.
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer.
Oncologist;
25(8): 661-668, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32202020
4.
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis.
Oncologist;
25(6): e928-e935, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31943506
5.
Determinants of choice in offering drug holidays during first-line therapy for metastatic colorectal cancer.
Future Oncol;
16(32): 2645-2660, 2020 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32776795
6.
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer.
Br J Cancer;
120(5): 522-526, 2019 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30745584
7.
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
BMC Cancer;
19(1): 283, 2019 Mar 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30922323
8.
Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials.
Br J Cancer;
118(7): 955-965, 2018 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29531324
9.
Sarcopenia in gastric cancer: when the loss costs too much.
Gastric Cancer;
20(4): 563-572, 2017 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28477106
10.
Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope.
Oncologist;
20(11): 1261-5, 2015 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26446234
11.
Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer.
Future Oncol;
11(4): 629-40, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25686118
12.
Risk of unplanned visits for colorectal cancer outpatients receiving chemotherapy: a case-crossover study.
Support Care Cancer;
22(9): 2527-33, 2014 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24728616
13.
The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer.
Cancers (Basel);
15(1)2022 Dec 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36612170
14.
Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer.
Cancers (Basel);
13(14)2021 Jul 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34298718
15.
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study.
Clin Cancer Res;
26(17): 4485-4493, 2020 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32371540
16.
Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial.
JAMA Oncol;
6(4): 547-551, 2020 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32053133
17.
A shared vaccination ambulatory for patients with cancer in Udine, Italy.
Tumori;
110(1): 74-76, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37904307
18.
Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial.
JAMA Oncol;
4(4): 529-536, 2018 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29450468
19.
Markers of the uPA system and common prognostic factors in breast cancer.
Am J Clin Pathol;
128(1): 112-7, 2007 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17580278
20.
Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic review.
Oncotarget;
8(39): 66699-66708, 2017 09 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29029548